Good quality stock which has completed technical set up
Technicals
The stock has corrected from covid market rally
Pre covid, the stock used to trade at higher PE, which is expected from good quality stock with max historical PE ( pre covid) in the range of 70-80
Currently the stock is at PE of 56, which shows good upward potential.
A contraction in price volatility is observed along with contaction in volume.
In the final move, you can see price is tightening even further, and trend is almost horizontal , which shows good support.
OMX25 market is starting to lift as well. The stock, even though a good quality one - rises and falls with market. So, I would not call it leader, but more of an influencer. So, keep an eye on market move
However, no shakeouts has been observed yet. so be careful before taking the big positions.
Remember, the key is to be "the last weak buyer" , so your stop losses are not triggered.
Fundamentals
The stock has unique cell counting product, witch significant market share, 30 % upwards gross margin and double digit CAGR and 15% plus ROIC. Which is decent enough for European market.
The stock has corrected from covid market rally
Pre covid, the stock used to trade at higher PE, which is expected from good quality stock with max historical PE ( pre covid) in the range of 70-80
Currently the stock is at PE of 56, which shows good upward potential.
A contraction in price volatility is observed along with contaction in volume.
In the final move, you can see price is tightening even further, and trend is almost horizontal , which shows good support.
OMX25 market is starting to lift as well. The stock, even though a good quality one - rises and falls with market. So, I would not call it leader, but more of an influencer. So, keep an eye on market move
However, no shakeouts has been observed yet. so be careful before taking the big positions.
Remember, the key is to be "the last weak buyer" , so your stop losses are not triggered.
Fundamentals
The stock has unique cell counting product, witch significant market share, 30 % upwards gross margin and double digit CAGR and 15% plus ROIC. Which is decent enough for European market.